Sfoglia per RIVISTA
CANCER
Collezione ASL Torino 4

  

Items : 4

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice. in Cancer / Cancer. 2021 Jun 15;127(12):2015-2024. doi: 10.1002/cncr.33472. Epub 2021 Mar 19.

2021
ASL Torino 4
ASL Biella
AOU Città della Salute di Torino
AOU Novara

Angelucci E; Musto P; Abbadessa A; Capalbo SF; Castelli A; Oliva EN; Centurioni R; Alesiani F; Catarini M; Bigazzi C; Crugnola M; Zambello R; Fanin R; Cametti G; Freilone R; Cilloni D; Di Tucci AA; Danise P; Selleri C; Poloni A; Finelli C; Balleari E; Ferrero D; Allione B; Salvi F; Ceccarelli M; Guolo F; Miglino M; Crisà E; et alii...

Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis in Cancer

2003
ASL Torino 4

Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N;

Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma: A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP) in Cancer

2001
ASL Torino 4

Parra HS; Tixi L; Latteri F; Bretti S; Alloisio M; Gravina A; Lionetto R; Bruzzi P; Dani C; Rosso R; Cosso M; Balzarini L; Santoro A; Ardizzoni A;

Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma: A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP) in Cancer

2001
ASL Torino 4

Parra HS; Tixi L; Latteri F; Bretti S; Alloisio M; Gravina A; Lionetto R; Bruzzi P; Dani C; Rosso R; Cosso M; Balzarini L; Santoro A; Ardizzoni A;